Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Sales | 779,703 | 736,603 | 666,810 | 760,231 | 657,782 |
| Gross Profit | 779,703 | 736,603 | 666,810 | 760,231 | 657,782 |
| Operating Income | 779,703 | 736,603 | 666,810 | 760,231 | 657,782 |
| Pre-tax Income | 779,703 | 736,603 | 666,810 | 760,231 | 657,782 |
| Net Income Continuous | 84,834 | 92,465 | 70,696 | 93,751 | 74,850 |
| Net Income | $84,834 | $92,465 | $70,696 | $93,751 | $74,850 |
| EPS Basic Total Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Basic Continuous Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted Total Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted Continuous Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EBITDA(a) | $779,703 | $736,603 | $666,810 | $760,231 | $657,782 |